Biopharma India Convention 2016

The move towards a more transparent regulatory regime in India is opening up its biopharma industry once again. With the widely available patient population and low manufacturing cost base, India remains an attractive destination for international biopharma players. But there are still challenges - quality assurance and control concerns need to be addressed if India wants to supply into the world’s most lucrative international markets. RandD also needs to be strongly supported, fostering an environment of innovation and encouraging new biotech start-ups to develop cutting-edge solutions and products. If we can tackle these challenges, India’s biopharma opportunity will be extraordinary. Welcome to BioPharma India 2016.